Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MOXI: Antioxidants for Male Infertility
NCT02421887Phase 2Completed
- Sponsor
- Yale University
- Start
- Dec 2015
- Primary completion
- Jun 2018
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by Yale University. Primary endpoint: Live Birth Rate at 15 months. Started Dec 2015; status: completed.
Beyond the preview
Go deeper on NCT02421887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02421887.